OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 02, 2019
Outsourcing of manufacturing activities is expected to increase in 2019.
While pharma is proving its capabilities to develop novel therapies, the industry still needs to work on manufacturing innovation.
Keeping valuable employees happy-and on the job-may test bio/pharma business decisions.
January 01, 2019
Intellectual challenge, work/life balance, compensation, and an unclear business outlook create uncertainty among European bio/pharma employees.
December 10, 2018
The company is investing approximately $14 million to expand biologics packaging capabilities and capacity at its biologics manufacturing facility in Bloomington, IN.
December 02, 2018
CMOs and CDMOs made investments in new and expanded facilities and services in the last quarter of 2018.
November 29, 2018
The contract research organization has increased its US-based early phase clinical capacity and doubled its specialty lab space.
November 27, 2018
Catalent will expand primary packaging capabilities and commission an automated, high-speed bottling line for clinical packaging of capsules and tablets.
November 26, 2018
ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.
November 20, 2018
With the $252-million acquisition of contract development, manufacturing, and testing organization Avista Pharma Solutions, Cambrex will enter the market for early stage small-molecule development and testing services.